ResearchMoz presents this most up-to-date research on "Market Landscape And Growth Prospects Of Global Pharmaceutical Contract Manufacturing Market During 2017 - 2020".
Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.
Technavios analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Catalent
Lonza
Pfizer CentreOne
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=867642
Other prominent vendors
Abbott
Aenova
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
BERLIN-CHEMIE
Biocon
Biogen
Boehringer Ingelheim
Celltrion
Cipla
Coherus Biosciences
Daiichi Sankyo
Market driver
High number of US FDA-approved manufacturing facilities in emerging countries.
For a full, detailed list, view our report
Market challenge
Capacity utilization issues and lack of information integration.
For a full, detailed list, view our report
Market trend
Huge demand for next-generation biologics.
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=867642
Contract manufacturing involves outsourcing manufacturing products to organizations, which helps the organizations offer the same services at a relatively lower cost. Typically, in the pharmaceutical and biotechnology sectors, the sourcing companies seek contract manufacturing services to restructure their resource deployment toward high skill areas such as R&D and marketing. Contract manufacturing has potential growth opportunities in emerging countries such as India and China.
Technavios analysts forecast the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global pharmaceutical contract manufacturing market for 2016-2020. To calculate the market size, the report considers the revenue generated from various pharmaceutical drug manufacturing outsourcing activities.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Pharmaceutical Contract Manufacturing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Catalent
Lonza
Pfizer CentreOne
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=867642
Other prominent vendors
Abbott
Aenova
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
BERLIN-CHEMIE
Biocon
Biogen
Boehringer Ingelheim
Celltrion
Cipla
Coherus Biosciences
Daiichi Sankyo
Market driver
High number of US FDA-approved manufacturing facilities in emerging countries.
For a full, detailed list, view our report
Market challenge
Capacity utilization issues and lack of information integration.
For a full, detailed list, view our report
Market trend
Huge demand for next-generation biologics.
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=867642
No comments:
Post a Comment